We are live on ! Find out more
CDLX icon

Cardlytics

195 hedge funds and large institutions have $3.97B invested in Cardlytics in 2020 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 53 increasing their positions, 72 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 23

112% more capital invested

Capital invested by funds: $1.87B → $3.97B (+$2.1B)

40% more funds holding in top 10

Funds holding in top 10: 1014 (+4)

19% more funds holding

Funds holding: 164195 (+31)

0.44% more ownership

Funds ownership: 9.76%10.2% (+0.44%)

24% less call options, than puts

Call options by funds: $34.4M | Put options by funds: $45.4M

26% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 72

Holders
195
Holders Change
+31
Holders Change %
+18.9%
% of All Funds
3.45%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.25%
New
55
Increased
53
Reduced
72
Closed
23
Calls
$34.4M
Puts
$45.4M
Net Calls
-$11M
Net Calls Change
-$18M

CDLX Hedge Fund Activity: Q4 2020 in Review

195 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2020, worth a combined $3.97B — up 112% from $1.87B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new CDLX positions and 23 closed out — a net gain of 32 holders — while 53 added to existing stakes and 72 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $79.5M. The largest seller was Wellington Management Group, cutting an estimated $43.7M.

  • 195 institutional investors held Cardlytics (CDLX) as of Q4 2020, up from 164 in Q3 2020.
  • Funds reported $3.97B of Cardlytics stock for Q4 2020, up 112% quarter-over-quarter.
  • 55 funds opened new Cardlytics positions in Q4 2020 and 23 closed out, a net change of +32 holders.
  • The largest Cardlytics buyer in Q4 2020 was JP Morgan Chase, an estimated $79.5M added.
  • The largest Cardlytics seller in Q4 2020 was Wellington Management Group, an estimated $43.7M sold.

Based on aggregated 13F filings for Q4 2020.